Prevention of neural-tube defects with periconceptional folic acid, methylfolate, or multivitamins?

Annals of Nutrition and Metabolism

Volumn 58, Issue 4, 2011, Pages 263-271

  Czeizel, Andrew E ^a   Dudás, István ^a   Paput, László ^b   Bánhidy, Ferenc ^c  

^a FOUNDATION FOR THE COMMUNITY CONTROL OF HEREDITARY DISEASES   (Hungary)

^b State Health Centre   (Hungary)

^c SEMMELWEIS UNIVERSITY   (Hungary)

Author keywords

Elective termination of affected fetuses; Folic acid; Methylfolate; Multivitamins; Neural tube defects; Prevention

Indexed keywords

FOLIC ACID; MULTIVITAMIN; ORAL CONTRACEPTIVE AGENT;

AMINO ACID METABOLISM; CONCEPTION; DIET SUPPLEMENTATION; HUMAN; HYPERHOMOCYSTEINEMIA; INCIDENCE; NEURAL TUBE DEFECT; PERICONCEPTION; PRENATAL DIAGNOSIS; PRIORITY JOURNAL; PUBLIC HEALTH SERVICE; RECURRENT DISEASE; REVIEW;

CONTRACEPTIVES, ORAL; DIET; DIETARY SUPPLEMENTS; DRUG COMBINATIONS; FEMALE; FOLIC ACID; FOOD, FORTIFIED; HUMANS; MATERNAL NUTRITIONAL PHYSIOLOGICAL PHENOMENA; NEURAL TUBE DEFECTS; PRECONCEPTION CARE; RECURRENCE; TETRAHYDROFOLATES; VITAMINS;

EID: 80051928219     PISSN: 02506807     EISSN: 14219697     Source Type: Journal    
DOI: 10.1159/000330776     Document Type: Review

References (36)

1. Smithells RW, Sheppard S, Wild J, Schorah CJ: Prevention of neural tube defect recurrences in Yorkshire: final report. Lancet 1989; 2: 498-499. (Pubitemid 19209157)
2. Nevin NC, Seller MJ: Prevention of neural tube defect recurrences. Lancet 1990; 1: 178-179. (Pubitemid 20032785)
3. MRC Vitamin Study Research Group: Prevention of neural tube defects: results of the Medical Research Council Vitamin Study. Lancet 1991; 338: 131-137.
4. Czeizel AE: Ten years of experience in the periconceptional care. Eur J Obstet Gynecol Reprod Biol 1999; 89: 43-49. (Pubitemid 29219416)
5. Czeizel AE, Dudás I: Prevention of the first occurrence of neural-tube defects by periconceptional vitamin supplementation. N Engl J Med 1992; 327: 1832-1835. (Pubitemid 23003073)
6. Czeizel AE, Dobó M, Vargha P: Hungarian cohort controlled trial of periconceptional multivitamin supplementation shows a reduction in certain congenital abnormalities. Birth Defects Res A Clin Mol Teratol 2004; 70: 853-861. (Pubitemid 39602196)
7. Berry RJ, Li Z, Erickson JD, Li S, Moore CA, Wang H, Li S, Moore CA, Wang H, Mulinare J, Zhao P, Wong LY, Gindler J, Hong SX, Correa A: Prevention of neural-tube defects with folic acid in China: China-US Collaborative Project for Neural Tube Defect Prevention. N Engl J Med 1999; 341: 1485-1490.
8. Wills L: Treatment of 'pernicious anaemia' of pregnancy and 'tropical anaemia' with special reference to yeast extract as a curative agent. Br Med J 1931; 1: 1059-1064.
9. Hoffbrand AV: The history of folic acid. Br J Haematol 2001; 113: 579-589. (Pubitemid 32524374)
10. Wilcken B, Bamforth F, Li Z, Ritvanen A, Redlund M, Stoll C, Alembik Y, Dott B, Czeizel AE, Gelman-Kohan Z, Scarano G, Bianca S, Ettore G, Tenconi R, Bellato S, Scala I, Mutchinick OM, López MA, de Walle H, Hofstra R, Joutchenko L, Kavteladze L, Bermejo E, Martinez-Frias ML, Gallagher M, Erickson JD, Vollset SE, Mastroiacovo P, Andria G, Botto LD: Geographical and ethnic variation of the 677C/T allele of 5,10 meth ylenetetrahydrofolate reductase (MTHFR): findings from over 7,000 newborns from 16 areas world wide. J Med Genet 2003; 40: 619-625. (Pubitemid 37046918)
11. Cuskelly GJ, McNulty H, Scott JM: Effect of increasing dietary folate on red-cell folate: implications for prevention of neural tube defects. Lancet 1996; 347: 657-659. (Pubitemid 26076133)
12. Busby A, Abramsky L, Dolk H, Armstrong B, Addor MC, Anneren G, Armstrong N, Baguette A, Barisic I, Berghold A, Bianca S, Braz P, Calzolari E, Christiansen M, Cocchi G, Daltveit AK, De Walle H, Edwards G, Gatt M, Gener B, Gillerot Y, Gjergja R, Goujard J, Haeusler M, Latos-Bielenska A, McDonnell R, Neville A, Olars B, Portillo I, Ritvanen A, Robert-Gnansia E, Rösch C, Scarano G, Steinbicker V: Preventing neural tube defects in Europe: a missed opportunity. Reprod Toxicol 2005; 20: 393-402. (Pubitemid 40943559)
13. CDC: Recommendations for the use of folic acid to reduce the number of cases of spina bifida and other neural tube defects. MMWR 1992; 41: 1233-1238.
14. McPartlin J, Halligan A, Scott JM, Garling M, Weir DG: Accelerated folate breakdown in pregnancy. Lancet 1993; 341: 148-149. (Pubitemid 23029309)
15. Daily LE, Kirke PN, Molloy A, Weir DG, Scott JM: Folate levels and neural tube defects. Implications for prevention. JAMA 1993; 274: 1698-1702.
16. Pietrzik K, Lamers Y, Brämswig S, Prinz-Langenohl R: Calculation of red blood cell folate steady state conditions and elimination kinetics after daily supplementation with various folate forms and doses in women in childbearing age. Am J Clin Nutr 2007; 86: 1414-1419. (Pubitemid 350126246)
17. Brämswig S, Prinz-Langenohl R, Lamers Y, Tobolski O, Wintergerst E, Berthold HK, Pietrzik K: Supplementation with a multivitamin containing 800 microg of folic acid shortens the time to reach the preventive red blood cell folate concentration in healthy women. Int J Vitam Nutr Res 2009; 79: 61-70.
18. Wright AJ, King MJ, Finglas PM: Folate-supplemented oral contraceptives: does 6S-5-methytetrahydrofolic acid (Metafolin) offer advantages over folic acid? Gynaecol Forum 2010; 15: 29-32.
19. Prinz-Langenohl R, Brämswig S, Tobolski O, Smulders YM, Smith DE, Finglas PM, Pietrzik K: [6S]-5-methyltetrahydrofolate increases plasma folate more effectively than folic acid in women with homozygous or wild-type 677C-T polymorphism of methylenetetrahydrofolate reductase. Br J Pharmacol 2009; 158: 2014-2021.
20. Pietrzik K, Bailey L, Shane B: Folic acid and L-5-methyltetrahydrofolate: comparison of clinical pharmacokinetics and pharmacodynamics. Clin Pharmacokinet 2010; 49: 535-548.
21. Lamers Y, Prinz-Langenohl R, Brämswig S, Pietrzik K: Red blood cell folate concentrations increase more after supplementation with [6S]-methyltetrahydrofolate than with folic acid in women of childbearing age. Am J Clin Nutr 2006; 84: 156-161. (Pubitemid 44699180)
22. Williams LJ, Mai C, Edmonds LD, Shaw GM, Kirby RS, Hobbs CA, Sever LE, Miller LA, Meaney FJ, Levitt M: Prevalence of spina bifida and anencephaly during the transition to mandatory folic acid fortification in the United States. Teratology 2002; 66: 33-39. (Pubitemid 34734388)
23. Grosse SD, Waltzman NJ, Romano PS, Mulinare J: Reevaluating the benefits of folic acid fortification in the United States: economic analysis, regulation, and public health. Am J Public Health 2005; 95: 1917-1922. (Pubitemid 41572361)
24. De Wals P, Tairou F, Van Allen M, Uh SH, Lowry RB, Sibbald B, Evans JA, Van den Hof MC, Zimmer P, Crowley M, Fernandez B, Lee NS, Niyonsenga T: Reduction in neuraltube defects after folic acid fortification in Canada. N Engl J Med 2007; 357: 135-142. (Pubitemid 47057731)
25. Wald NJ, Law MR, Morris JK, Wald DS: Quantifying the effects of folic acid. Lancet 2001; 358: 2069-2073.
26. Fenech M: The role of folic acid and vitamin B 12 in genomic stability of human cells. Mutat Res 2001; 475: 57-67. (Pubitemid 32280803)
27. Oakley GP: Inertia on folic acid fortification: public health malpractice. Teratology 2002; 66: 44-54.
28. Holzgreve W: Adding folate to the pill to prevent neural tube defects. Gynaecol Forum 2010; 15: 4-8.
29. Szarevsky A: Oral contraceptive and pregnancy planning. Gynaecol Forum 2010; 15: 23-28.
30. Oakley D, Sereika S, Bogue EL: Oral contraceptive pill use after an initial visit to a family planning clinic. Fam Plann Perspect 1991; 23: 151-154.
31. Rosenberg MJ, Waugh MS: Oral contraceptives discontinuation: a prospective evaluation of frequency and reasons. Am J Obstet Gynecol 1998; 179: 577-582. (Pubitemid 28447229)
32. Cronin M, Schellschmidt I, Dinger J: Rate of pregnancy after using drosperinone and other progestin-containing oral contraceptives. Obstet Gyneco 2009; 114: 616-622.
33. Dunson DB, Baird DD, Colombo B: Increased infertility with age in men and women. Obstet Gynecol 2004; 103: 51-56. (Pubitemid 39248466)
34. Periodic health examination, 1994 update. 3. Primary and secondary prevention of neural tube defects-Canadian Task Force on the Periodic Health Evaluation. CMAJ 1994; 151: 21-28.
35. Czeizel AE, Vargha P: Periconceptional folic acid/multivitamin supplementation and twin pregnancy. Am J Obstet Gynecol 2004; 1891: 790-794. (Pubitemid 39298111)
36. Valek A, Béres J, Métneki J: Efficiency of prenatal screening of congenital abnormalities on the basis of the Hungarian Congenital Abnormality Registry and Surveillance. Magy Epidemiol 2010; 7:S11-S12.